If you invest in the stock market, you must know the Pfizer stock forecast & price prediction for 2025, 2026, 2027, 2028, 2029, and 2030. Here, you will get the detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Join Us On WhatsApp GroupPfizer Inc (PFE) Company Overview
In 1849, Charles Fizer and Charles F. Erhart founded Pfizer Inc., a leading American multinational pharmaceutical and biotechnology corporation headquartered in The Spiral, New York City.
With a mission to deliver life-changing breakthroughs to patients, Pfizer focuses on developing and manufacturing medicines and vaccines in diverse therapeutic areas, including immunology, oncology, cardiology, endocrinology, and neurology.
Under the leadership of Chairman and CEO Albert Bourla, Pfizer has achieved significant milestones, most notably the development of the Pfizer-BioNTech COVID-19 vaccine, which generated $11 billion in revenue in 2023.
The company’s diverse portfolio also includes well-known products such as Eliquis (a blood thinner), Prevnar (a pneumococcal vaccine), and Ibrance (a treatment for breast cancer). The company continues to invest in research and development, with a focus on innovative areas such as gene therapy, mRNA technology, and artificial intelligence, aimed at addressing unmet medical needs and improving global health outcomes.
Pfizer Inc. (PFE) Fundamental Analysis
| Market Cap | $134,924 Mln. |
| ROE | 0.09% |
| ROCE | 5.08% |
| P/E Ratio | 16.87 |
| P/B Ratio | 1.56 |
| Div. Yield | 7.23% |
| Book Value | — |
| EPS (TTM) | $1.38 |
| 52 Week High | $31.54 |
| 52 Week Low | $20.92 |
Also Read: Rivian Stock Forecast
Pfizer Stock Forecast 2025
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $27.18 by early 2025.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $27.12
By the end of 2025, Pfizer’s stock price can achieve the target of $30.75.
| Year 2025 | |
|---|---|
| Starting Price | $27.18 |
| Mid-Year Price | $27.12 |
| Ending Price | $30.75 |
Pfizer Stock Forecast 2026
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $31.12 by early 2026.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $33.85.
By the end of 2026, Pfizer’s stock price can achieve the target of $36.70.
| Year 2026 | |
|---|---|
| Starting Price | $31.12 |
| Mid-Year Price | $33.85 |
| Ending Price | $36.70 |
Pfizer Stock Forecast 2027
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $37.24 by early 2027.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $39.56.
By the end of 2027, Pfizer’s stock price can achieve the target of $42.10.
| Year 2027 | |
|---|---|
| Starting Price | $37.24 |
| Mid-Year Price | $39.56 |
| Ending Price | $42.10 |
Also Read: Dell Stock Forecast
Pfizer Stock Forecast 2028
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $189.43 by early 2028.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $202.35.
By the end of 2028, Pfizer’s stock price can achieve the target of $218.50.
| Year 2028 | |
|---|---|
| Starting Price | $189.43 |
| Mid-Year Price | $202.35 |
| Ending Price | $218.50 |
Pfizer Stock Forecast 2029
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $50.30 by early 2029.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $53.24.
By the end of 2029, Pfizer’s stock price can achieve the target of $56.18.
| Year 2029 | |
|---|---|
| Starting Price | $50.30 |
| Mid-Year Price | $53.24 |
| Ending Price | $56.18 |
Pfizer Stock Forecast 2030
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $57.10 by early 2030.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $60.42.
By the end of 2030, Pfizer’s stock price can achieve the target of $63.00.
| Year 2030 | |
|---|---|
| Starting Price | $57.10 |
| Mid-Year Price | $60.42 |
| Ending Price | $63.00 |
Also Read: Apple Stock Forecast
Pfizer Stock Forecast & Price Prediction 2025 To 2030
| Year | Stock Price Forecast |
|---|---|
| 2025 | $30.75 |
| 2026 | $36.70 |
| 2027 | $42.10 |
| 2028 | $49.65 |
| 2029 | $56.18 |
| 2030 | $63.00 |
Pfizer Inc. Major Holdings
| Shares Held by All Insider | 0.06% |
| Shares Held by Institutions | 67.60% |
| Float Held by Institutions | 67.63% |
| Number of Institutions Holding Shares | 3,677 |
Also Read: Nvidia (NVDA) Stock Forecast
Pfizer Inc. (PFE) Financials
| Income Statement | ||
|---|---|---|
| Category | 2024 Value | Y/Y Change |
| Revenue | $63.63B | 6.84% |
| Operating Expense | $30.88B | 5.58% |
| Net Income | $8.03B | 279.00% |
| Net Profit Margin | 12.62% | 254.49% |
| Earnings Per Share | $3.11 | 69.02% |
| EBITDA | $23.32B | 24.22% |
| Effective Tax Rate | -0.35% | — |
| Balance Sheet | ||
|---|---|---|
| Category | 2024 Value | Y/Y Change |
| Cash & Short-Term Investments | $20.48B | 61.36% |
| Total Assets | $213.40B | -5.79% |
| Total Liabilities | $124.90B | -8.97% |
| Total Equity | $88.50B | — |
| Shares Outstanding | 5.67B | — |
| Price to Book | 1.43 | — |
| Return on Assets | 4.64% | — |
| Return on Capital | 6.37% | — |
| Cash Flow Statement | ||
|---|---|---|
| Category | 2024 Value | Y/Y Change |
| Net Income | $8.03B | 279.00% |
| Cash From Operations | $12.74B | 46.48% |
| Cash From Investing | $2.65B | 108.22% |
| Cash From Financing | -$17.14B | -165.76% |
| Net Change in Cash | -$1.81B | -173.91% |
| Free Cash Flow | $12.78B | 129.78% |
Also Read: Mr Cooper Group (COOP) Stock Forecast
Pfizer Inc (PFE) Top Shareholders
| Company | Percentage |
|---|---|
| Vanguard Group Inc | 9.14% |
| Blackrock Inc. | 7.97% |
| State Street Corporation | 5.12% |
| Charles Schwab Investment Management, Inc. | 2.74% |
| Wellington Management Group, LLP | 2.47% |
| Geode Capital Management, LLC | 2.13% |
| NORGES BANK | 1.55% |
| Massachusetts Financial Services Co. | 1.35% |
| Morgan Stanley | 1.30% |
| Northern Trust Corporation | 1.03% |
Disclaimer: The stock market updates shared by DateUpdateGo are solely for general information and learning purpose only. They are not meant to serve as an investment advice. Individuals should always seek guidance from a certified financial advisor before making any investment-related choices.